Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Parkinson 08. May 2026
Search
medline.ch
Parkinson
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2869  Previews Next
   
   Articles 1 - 20 / 57361  
   
Evaluating the clinical effects of GLP-1 receptor agonists for Alzheimer's and Parkinson's diseases using minimal clinically important difference: systematic review and meta-analysis.
Arch Pharm Res
Elghanam Y, Kim E.
PMID: 42098470 [PubMed - as supplied by publisher]


Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.
Neurol Ther
Jost WH, Bergquist F, Evans A, Hassin-Baer S, Hauser RA, Henriksen T, Malaty IA, Mestre TA, Mir P, Rodriguez R, Schwingenschuh P, Simu M, Bergmann L, Zhou TT, Caughlin S, Gopalkrishnan M, Kukreja P, O'Meara M, Parra JC, Shah MB, Aldred J.
PMID: 42098450 [PubMed - as supplied by publisher]


Comment on "Association of Gastrointestinal Symptoms With Severity and Progression of Cognitive Impairment in Parkinson's Disease: A Systematic Review and Meta-Analysis".
J Gastroenterol Hepatol
Li SN, Shen XJ, Yao YH, Liu L.
PMID: 42097856 [PubMed - as supplied by publisher]


Conjecture for a free radical epimerization process in Alzheimer, Parkinson, Lewy body, amyotrophic lateral sclerosis, progressive Supranuclear Palsy and Creutzfeldt Jakob diseases.
Exp Neurol
Deloncle R.
PMID: 42097486 [PubMed - as supplied by publisher]


Reimagining the contribution of iron in Parkinson's disease.
Neurobiol Dis
Serpa RO, Tufano E, Connor JR.
PMID: 42097406 [PubMed - as supplied by publisher]


Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects.
Int Immunopharmacol
Dong S, Lu J, Wu L, Wang S, Gong Y, Hu J, Liu Y, Chen X.
PMID: 42096963 [PubMed - as supplied by publisher]


Examining Sensory Systems That Contribute to Falls in Parkinson Disease Using Computerized Dynamic Posturography: Secondary Analysis.
JMIR Form Res
Rivera M.
PMID: 42096603 [PubMed - indexed for MEDLINE]


One world, one goal: Advocacy and policy for a unified Parkinson's response.
J Parkinsons Dis
Fothergill-Misbah N.
PMID: 42096181 [PubMed - as supplied by publisher]


Photonic and nanomaterial-driven optical biosensing strategies for Parkinson's disease.
Mikrochim Acta
Soni D, Ratre P.
PMID: 42096083 [PubMed - indexed for MEDLINE]


Heterocyclic Derivatives in Parkinson's Therapy: Recent Advances and Prospects.
Med Chem
Kanupriya, Sharma V, Verma SP, Mishra I, Mittal RK, Biswas T, Mishra R.
PMID: 42095489 [PubMed - indexed for MEDLINE]


Resveratrol and the neuroinflammation axis in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and cerebral ischemia.
Front Immunol
Wang H, Li F, Wang H, Tian Z, Fan H, Shi Z.
PMID: 42093988 [PubMed - indexed for MEDLINE]


Suicidal behaviour and suicide mortality in Parkinson's disease: a nationwide register-based cohort study.
BMJ Neurol Open
Lindström S, Wolfschlag M, Cedergren Weber G, Ljung H, Hĺkansson A, Odin P, Berge J.
PMID: 42093830 [PubMed]


The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson's disease.
Transl Neurodegener
Shimizu T, Isik S, Kamath N, Yue Z.
PMID: 42093006 [PubMed - indexed for MEDLINE]


Validation of remote multimodal AI screening for Parkinson disease across diverse settings.
Commun Med (Lond)
Islam MS, Adnan T, Abdelkader A, Liu Z, Ma E, Park S, Azad A, Liu P, Pawlik M, Hartman E, Shelton E, Larson KB, Rahman MS, Schwartz C, Jaffe K, Adams JL, Schneider RB, Freyberg J, Dorsey ER, Hoque E.
PMID: 42092025 [PubMed - as supplied by publisher]


Clinical GDNF delivery methods for Parkinson's disease.
J Parkinsons Dis
Luz M, Fiandaca MS, Bankiewicz KS.
PMID: 42091584 [PubMed - as supplied by publisher]


Sensorimotor integration and functional mobility in early-stage Parkinson's disease: A cross-sectional study using clinically feasible assessments.
PLoS One
ALMohiza MA, Reddy RS.
PMID: 42090401 [PubMed - indexed for MEDLINE]


Hippocampal atrophy in untreated de novo Parkinson's disease with obstructive sleep apnea.
NPJ Parkinsons Dis
Burdová K, R, Mana J, Filip P, Nepo, Dostálová S, Pe, Bezdicek O, Gregorovi, Havlík F, R, Du, , Jech R.
PMID: 42086584 [PubMed - as supplied by publisher]


The Influence of Progressive Speech Rehabilitation Combined with Personalised Noise-Reduced Auditory Scenery on Language Function and Gait Outcomes in Patients with Parkinson's Disease.
Noise Health
Tong X, Liu X, Zhao J.
PMID: 42085100 [PubMed - indexed for MEDLINE]


Advances in sex-specific single-cell transcriptomic profiling in Parkinson's disease.
J Parkinsons Dis
Hoof V, Schulze-Hentrich J.
PMID: 42084601 [PubMed - as supplied by publisher]


Risk of Alzheimer Disease and Other Dementias in Patients With Parkinson Disease: A Nationwide Cohort Study.
Alzheimer Dis Assoc Disord
Bae Y, Kim M, Jeon SR, Lee SW, Jung H.
PMID: 42084241 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 57361    Page 1 of 2869  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1